💊FDA批准基因疗法Luxturna为遗传性失明 💊FDA批准基因疗法Luxt 12/20/17 WednesdayBy Tokio X'press FDA, Statistics, Pharmaceutical Pfizer, Luxturna, ONO 💊FDA批准基因疗法Luxt
💊FDA PHARMA today 💊FDA PHARMA to 12/19/17 TuesdayBy Tokio X'press offices, FDA, Pharmaceutical ONO 💊FDA PHARMA to
💊默克的Keytruda错过了胃癌的主要终点 💊默克的Keytruda错过 12/16/17 SaturdayBy Tokio X'press FDA, Pharmaceutical Merck's 💊默克的Keytruda错过
💊FDA PHARMA今天 💊FDA PHARMA今天< 12/14/17 ThursdayBy Tokio X'press FDA, Pharmaceutical Bristol-Myers Squibb, Pfizer, Bayer 💊FDA PHARMA今天<